Comparison of Vancomycin AUC24 Calculation Methods for Neonates and Infants.

IF 1.9 4区 医学 Q3 PHARMACOLOGY & PHARMACY European Journal of Drug Metabolism and Pharmacokinetics Pub Date : 2024-11-01 Epub Date: 2024-10-22 DOI:10.1007/s13318-024-00920-5
Tuomas Laitila, Ulla Sankilampi, Marjo Renko, Merja Kokki, Veli-Pekka Ranta
{"title":"Comparison of Vancomycin AUC24 Calculation Methods for Neonates and Infants.","authors":"Tuomas Laitila, Ulla Sankilampi, Marjo Renko, Merja Kokki, Veli-Pekka Ranta","doi":"10.1007/s13318-024-00920-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>For neonates and infants receiving intermittent vancomycin infusions, the area under the concentration-time curve during 24 h (AUC24) is often estimated with Bayesian forecasting using one or more measured vancomycin concentrations. When practical peak and trough concentrations are measured at steady state, AUC24 can also be calculated with first-order steady-state equations for a one-compartment model (Sawchuk-Zaske method), but previously this method has been applied only for adults. The objective of this study was to compare AUC24 values obtained with the Sawchuk-Zaske method and two Bayesian models.</p><p><strong>Methods: </strong>AUC24 values were estimated retrospectively for 18 neonates and infants with steady-state peak and trough concentrations using traditional compartmental analysis with a one-compartment model (reference method), the Sawchuk-Zaske method, and Bayesian forecasting with two previously published models. In Bayesian forecasting, both original and modified residual error models were used. In the modified models, the residual error was reduced by setting the additive residual error to zero and the proportional error to 15%.</p><p><strong>Results: </strong>AUC24 estimates obtained with the Sawchuk-Zaske method differed - 2.7 to 0.9% from the reference method. When both peak and trough concentrations were used in Bayesian forecasting, 61% and 33% of AUC24 estimates obtained with two original models differed less than 15% from the reference method, and these fractions increased to 83% and 72% with the modified models, respectively.</p><p><strong>Conclusion: </strong>When practical peak and trough concentrations are measured at steady state, the simple Sawchuk-Zaske method is very useful for AUC24 estimation in neonates and infants. In Bayesian forecasting, the reduced residual error model can be used to improve the model fit.</p>","PeriodicalId":11939,"journal":{"name":"European Journal of Drug Metabolism and Pharmacokinetics","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11549144/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Drug Metabolism and Pharmacokinetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13318-024-00920-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective: For neonates and infants receiving intermittent vancomycin infusions, the area under the concentration-time curve during 24 h (AUC24) is often estimated with Bayesian forecasting using one or more measured vancomycin concentrations. When practical peak and trough concentrations are measured at steady state, AUC24 can also be calculated with first-order steady-state equations for a one-compartment model (Sawchuk-Zaske method), but previously this method has been applied only for adults. The objective of this study was to compare AUC24 values obtained with the Sawchuk-Zaske method and two Bayesian models.

Methods: AUC24 values were estimated retrospectively for 18 neonates and infants with steady-state peak and trough concentrations using traditional compartmental analysis with a one-compartment model (reference method), the Sawchuk-Zaske method, and Bayesian forecasting with two previously published models. In Bayesian forecasting, both original and modified residual error models were used. In the modified models, the residual error was reduced by setting the additive residual error to zero and the proportional error to 15%.

Results: AUC24 estimates obtained with the Sawchuk-Zaske method differed - 2.7 to 0.9% from the reference method. When both peak and trough concentrations were used in Bayesian forecasting, 61% and 33% of AUC24 estimates obtained with two original models differed less than 15% from the reference method, and these fractions increased to 83% and 72% with the modified models, respectively.

Conclusion: When practical peak and trough concentrations are measured at steady state, the simple Sawchuk-Zaske method is very useful for AUC24 estimation in neonates and infants. In Bayesian forecasting, the reduced residual error model can be used to improve the model fit.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新生儿和婴儿万古霉素 AUC24 计算方法的比较。
背景和目的:对于接受间歇性万古霉素输注的新生儿和婴儿,通常使用贝叶斯预测法(Bayesian forecasting)利用一个或多个万古霉素测量浓度来估算 24 小时内的浓度-时间曲线下面积(AUC24)。当在稳态时测量到实际的峰值和谷值浓度时,也可使用一室模型的一阶稳态方程(Sawchuk-Zaske 法)计算 AUC24,但以前这种方法仅适用于成人。本研究的目的是比较用 Sawchuk-Zaske 法和两种贝叶斯模型得出的 AUC24 值:采用传统的一室模型(参考方法)、Sawchuk-Zaske 法和贝叶斯预测法,对 18 名新生儿和婴儿的 AUC24 值进行了回顾性估算,并得出了稳态峰值和谷值浓度。在贝叶斯预测法中,使用了原始和修正的残余误差模型。在修正模型中,通过将加性残余误差设为零和将比例误差设为 15%,减少了残余误差:结果:使用 Sawchuk-Zaske 方法获得的 AUC24 估计值与参考方法的差异为 2.7% 至 0.9%。当在贝叶斯预测中同时使用峰值和谷值浓度时,使用两个原始模型得到的 AUC24 估计值中,分别有 61% 和 33% 与参考方法的差异小于 15%,而使用修改后的模型时,这两个比例分别增加到 83% 和 72%:当在稳态时测量到实际的峰值和谷值浓度时,简单的 Sawchuk-Zaske 方法对新生儿和婴儿的 AUC24 估计非常有用。在贝叶斯预测中,减少残余误差模型可用于改善模型拟合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
64
审稿时长
>12 weeks
期刊介绍: Hepatology International is a peer-reviewed journal featuring articles written by clinicians, clinical researchers and basic scientists is dedicated to research and patient care issues in hepatology. This journal focuses mainly on new and emerging diagnostic and treatment options, protocols and molecular and cellular basis of disease pathogenesis, new technologies, in liver and biliary sciences. Hepatology International publishes original research articles related to clinical care and basic research; review articles; consensus guidelines for diagnosis and treatment; invited editorials, and controversies in contemporary issues. The journal does not publish case reports.
期刊最新文献
Hypertensive Nephropathy Changes the Expression of Drug-Metabolizing Enzymes and Transporters in Spontaneously Hypertensive Rat Liver and Kidney. Physiologically-Based Pharmacokinetic Modeling of Trofinetide in Moderate Renal Impairment for Phase 1 Clinical Study Dose Selection with Model Validation. Does Age Influence Immunosuppressant Drug Pharmacokinetics in Kidney Transplant Recipients? Pharmacokinetic and Pharmacodynamic Interaction of Finerenone with Diltiazem, Fluconazole, and Ritonavir in Rats. Prediction of First-in-Human Dose of Chimeric Antigen Receptor-T (CAR-T) Cells from Mice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1